Share-based Compensation (Tables)

12 Months Ended

Dec. 31, 2021

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Share-Based Compensation Expense and Related Tax Benefits

The table below provides the share-based compensation expense and related tax benefits for the periods indicated:

	Year Ended December 31,
	2021		2020		2019
Share-based compensation expense	$	2,436	$	2,544	$	3,125
Related tax benefits	$	703	$	734	$	941

Summary of Information under Plans

The following information under the Plans is presented for the periods indicated:

	Year Ended December 31,
	2021		2020		2019
Total intrinsic value of options exercised (1)	$	—	$	—	$	842
Cash received from options exercised	$	—	$	—	$	2,979

⁽¹⁾ Intrinsic value represents the difference between the closing stock price on the exercise date and the exercise price, multiplied by the number of options.

Summary of Stock Option Transactions under Plans

The following is a summary of stock option transactions under the Plans for the periods indicated:

	Year Ended December 31,
	2021					2020					2019
	Number of Shares			Weighted- Average Exercise Price Per Share		Number of Shares			Weighted- Average Exercise Price Per Share		Number of Shares			Weighted- Average Exercise Price Per Share
Options outstanding at beginning of period		125,938		$	19.59		156,438		$	18.84		338,338		$	17.52
Options exercised		—		$	—		—		$	—		(181,900	)	$	16.38
Options forfeited		(10,000	)	$	19.74		(30,500	)	$	15.73		—		$	—
Options outstanding at end of period		115,938		$	19.58		125,938		$	19.59		156,438		$	18.84
Options exercisable at end of period		115,938		$	19.58		125,938		$	19.59		156,438		$	18.84

Summary of Stock Options Outstanding under Plans

As of December 31, 2021, stock options outstanding under the Plans were as follows:

	Options Outstanding								Options Exercisable
	Number of Shares		Intrinsic Value (1)		Weighted- Average Average Exercise Price Per Share		Weighted- Average Remaining Contractual Life		Number of Shares		Intrinsic Value (1)		Weighted- Average Exercise Price Per Share		Weighted- Average Remaining Contractual Life
$10.80 to $14.99		4,938	$	55	$	12.54		0.95		4,938	$	55	$	12.54		0.95
$15.00 to $19.99		50,000		363		16.43		1.66		50,000		363		16.43		1.66
$20.00 to $24.83		61,000		61		22.73		2.84		61,000		61		22.73		2.84
		115,938	$	479	$	19.58		2.30		115,938	$	479	$	19.58		2.30

⁽¹⁾ Intrinsic value represents the difference between the closing stock price on the last trading day of the period, which was $23.68 as of December 31, 2021, and the exercise price, multiplied by the number of options. This value is presented in thousands.

Schedule of Restricted Stock Awards under 2013 Plan

The table below provides information for restricted stock awards under the 2013 Plan for the periods indicated:

	2021					2020					2019
	Number of Shares			Weighted- Average Grant Date Fair Value Per Share		Number of Shares			Weighted- Average Grant Date Per Share		Number of Shares			Weighted- Average Grant Date Fair Value Per Share
Restricted stock at beginning of period		243,708		$	15.60		296,201		$	22.91		304,595		$	21.98
Restricted stock granted		75,679		$	19.62		125,896		$	8.51		181,204		$	22.05
Restricted stock vested		(134,659	)	$	16.01		(137,892	)	$	24.68		(99,527	)	$	27.56
Restricted stock forfeited		(32,641	)	$	15.02		(40,497	)	$	16.55		(90,071	)	$	13.78
Restricted stock at end of period		152,087		$	17.24		243,708		$	15.60		296,201		$	22.91